alexa The Implications of the BRCA Gene Patent Rulings for Individualized Medicine | OMICS International| Abstract
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Clinic Experiment Pathol 2011, Vol 1(1): e101
  • DOI: 10.4172/2161-0681.1000e101

The Implications of the BRCA Gene Patent Rulings for Individualized Medicine

Mark A. Nelson*
Professor of Pathology, University of Arizona, USA
*Corresponding Author : Mark A. Nelson, Ph. D. Professor of Pathology, University of Arizona1501 N. Campbell AvenueTucson, Arizona, USA, Tel: 520 626 2619, Fax: 520 626 1027, Email: [email protected]

Received Date: Aug 11, 2011 / Accepted Date: Sep 05, 2011 / Published Date: Nov 12, 2011

Citation: Nelson MA (2011) The Implications of the BRCA Gene Patent Rulings for Individualized Medicine. J Clinic Experiment Pathol 1:e101. Doi: 10.4172/2161-0681.1000e101

Copyright: © 2011 Nelson MA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 11954
  • [From(publication date): 11-2011 - Feb 28, 2020]
  • Breakdown by view type
  • HTML page views: 8136
  • PDF downloads: 3818
Top